Skip to content

Press Release · Press Releases · Asia-Pacific

CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets

Issued by PR Newswire

Image: PR Newswire

SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ -- CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to the international medical aesthetics industry. SOLTOX is...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories